Corporate Grapevine     

Published: June 30, 2025
Updated: June 30, 2025

Torrent tastes IPL, eyes J. B. Chem.

After acquiring an Indian Premier League (IPL) cricket franchise for Rs 5,000 crore, the Mehtas of the Torrent group are now preparing to acquire JB Chemi cals and Pharmaceuticals from US-based private equity giant KKR & Co for $ 3 billion in total equity valuation.

The Ahmedabad-based Torrent group, founded by UN Mehta and now led by brothers Samir and Sudhir Mehta, has built a diversified business span ning pharmaceuticals and power. Despite their sizable footprint and growing influence, the Mehtas maintain a low public profile and prefer to operate away from the media glare — unlike many of their Mumbai-based peers.

Torrent Pharmaceuticals, the group’s flagship pharma company, is in ad vanced talks to buy KKR’s 47.84 per cent stake in JB Chemicals, a move that would trigger a mandatory open offer under Indian takeover regulations. As of the last market close, the stake was valued at Rs 13,461 crore.

The deal would further consolidate Torrent’s position in the Indian pharmaceutical market and strengthen its portfolio in branded generics. Insiders say it’s the new generation, who are now entering the workforce, who are leading the acquisition spree. Keep an eye on GenNext of the Mehtas.